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ABSTRACT
The prevalence of tramadol misuse in Nigeria and lack of a quantitative and valid instrument 
to assess knowledge on the use and misuse of tramadol necessitated this study. The 
objective of this studywas to develop and validate a questionnaire to assess knowledge 
about tramadol use and misuse among tramadol users in Benue State of Nigeria. A mixed-
method design was used. Literature review and focus group discussions were conducted 
to generate items for the questionnaire. Six experts were involved in content validation. 
The item-level content validity index (I-CVI) cut-off point was set at 0.83. Chain-referral 
sampling method was applied. Data were collected from tramadol users (n = 200) for 
the validation study. Item response theory model was applied in the assessment of the 
psychometric properties of the questionnaire. Cronbach alpha was computed to determine 
the internal consistency. Ten items were initially deleted for failing to meet the I-CVI cut-off 
point (I-CVIs < 0.83). The over-all CVI of the questionnaire was 0.86. Five more items were 
deleted for poor performance in both the difficulty and discrimination parameters, leaving 
35 items for the final questionnaire. The reliability coefficient was 0.78 indicating good 
internal consistency. A valid and reliable self-report questionnaire therefore, emerged 
for the assessment of knowledge about tramadol in five domains including medical use, 
prescription, misuse, effects of misuse and withdrawal/detoxification. The questionnaire 
can serve as a valid and reliable tool for assessment of knowledge about tramadol and for 
evaluation of intervention efforts at curtailing tramadol abuse.
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Tramadol is a prescription analgesic 
mainly indicated for providing relief for 
moderate to moderately severe pains. 
However, there are indications that tra-
madol as a pharmaceutical opioid is ad-
dictive and liable to misuse (Babalonis, 
Lofwall, Nuzzo, Siegel, & Walsh, 2013; 
Pollice et al., 2008; Sansone & Sansone, 
2009; Zhang & Liu, 2013). Misuse of tra-
madol reflects in the use of the drug for 
a purpose that is not consistent with the 
medical or legal guidelines or using it in 
a manner or dose other than prescribed. 
For example, using tramadol for sexual 
stamina, work performance, euphoria 
and for several purposes other than pain 
treatment indicates misuse. 
A report by the National Bureau of 
Statistics (2018), shows that 4.6 million 
people have misused tramadol in Nigeria. 
The high prevalence of tramadol misuse 
in Nigeria could be attributed partly to 
non-regulation of tramadol at the inter-
national level and its’ availability at cheap 
prices (less than $1 for a 10-tablet strip 
of 100 mg) at Nigerian pharmacies which 
do not require prescription notes before 
selling out (Kayode, 2019). There is also 
illicit production of tramadol in Nigeria 
in addition to the huge, smuggled tab-
lets. Report has it that in 2018, the Nige-
rian authorities seized illegal shipments 
of about 2 billion tablets of tramadol at 
the ports (Kayode, 2019). This indicates a 
booming market for tramadol in Nigeria 
whose youths are increasingly using the 
drug for non-medical purposes. The be-
lief that tramadol serves as a remedy for 
premature ejaculation, extends orgasm 
and increases work performance has 
contributed to its popularity and mas-
sive use among Nigerian youths (Chikezie 
& Ebuenyi, 2019; Ibrahim et al., 2017; 
Orhero, 2018).
The alarming rate of tramadol misuse 
by young people has posed a serious 
health challenge globally as it is known 
to have dire health consequences ranging 
from mild effects like headache, stomach-
ache, itchy skin and painful urination to 
severe long-term effects like psychiatric 
disorder, seizure, serotonin syndrome, 
cardiovascular collapse and respiratory 
depression (El-Hadidy & Helaly, 2015; 
Sansone & Sansone, 2009). A report on 
drug use shows that 450,000 people died 
in 2015 worldwide as a result of drug 
use. Out of that figure, 167,750 deaths 
were linked to drug use disorders in most 
cases involving misuse of pharmaceuti-
cal opioids like tramadol, morphine and 
codeine (United Nations Office on Drugs 
and Crime, 2018). The United States Sub-
stance Abuse and Mental Health Services 
Administration also reported that from 
2005 to 2011, Emergency Departments 
visits for tramadol-related misuse or 
abuse increased 250% from 6,255 in 2005 
to 21,649 in 2011 (Bush, 2013). In North-
ern Ireland, it was reported that tramadol 
abuse-related deaths represented 48% of 
all drug misuse in 2011 (Randall & Crane, 
2014). Tramadol misuse has also been 
linked to acts of violence and criminality. 
For example, cases of robbery, rape, stab-
bing and Boko Haram activities were re-
ported to have been fuelled by tramadol 
misuse in Gabon, Ghana and Nigeria (BBC, 
2018; Ebo, 2018). These threats to health 
and wellbeing as well as to security posed 
by tramadol misuse are worrisome.
The importance of assessing knowledge 
on drugs cannot be over-emphasized. This 
is because, knowledge about drugs has 
been shown to wield influence on attitude 
and behaviour relating to drug use (Barati, 
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2014; Embleton, Ayuku, Atwoli, Vreeman, 
& Braitstein, 2012; Geramian, Akhavan, 
Gharaat, Tehrani, & Farajzadegan, 2012). 
The knowledge of prescription status of 
drugs and their indications and contrain-
dications would play a significant role in 
the correct use of drugs and in avoiding 
self-medication and its attendant conse-
quences. It is, however, unfortunate that a 
thorough literature search has shown that 
there is no valid and reliable questionnaire 
that could be used to assess knowledge 
about tramadol among individuals who 
use the drug. Several studies that report-
ed on knowledge about tramadol did not 
use any questionnaire with psychometric 
properties (Elliason, 2018; Fuseini, Afizu, 
Yakubu, & Nachinab, 2019; Tafesh, 2013). 
The objective of this study was, therefore, 
to develop and validate a questionnaire to 
assess knowledge about tramadol use and 
misuse among tramadol users in Benue 
State of Nigeria.
METHOD
A mixed-method design combining a 
qualitative approach with quantitative 
procedure was applied in developing the 
instrument named ‘tramadol use and mis-
use knowledge assessment questionnaire 
(TUMKAQ)’. Two stages were involved in 
developing this questionnaire. The first 
stage involves item and domain genera-
tion while the second stage was concerned 
with the validation of the questionnaire 
by content, face, and construct validation 
methods as well as test of reliability.
First Stage: Items and Domains 
Generation
The process of generating items for 
the development of this questionnaire 
began with a thorough literature review 
by accessing several databases (psycINFO, 
PubMed, googlescholar, Drug Database, 
Scopus, MEDLINE, Web of science, socio-
logical Abstracts and others) to ascertain 
whether there was any valid and reliable 
knowledge assessment instrument on 
tramadol use and misuse, but none was 
found. We, therefore, deemed it neces-
sary and timely to develop a question-
naire that will fill this important gap in 
drug research. Literature review was also 
conducted on indications and contraindi-
cations of tramadol, prescription status, 
and dosage requirement. Other areas 
that the review covered include trama-
dol abuse and misuse, tolerance, depen-
dence and addiction, effects of tramadol 
abuse and misuse, withdrawal symptoms, 
safe-withdrawal from tramadol and de-
toxification.
To support the information from lit-
erature, three sessions of focus group 
discussions (FGDs) were conducted with 
two groups of tramadol users (eight par-
ticipants each) and one group of psychia-
trists (eight participants) working in ter-
tiary health institutions in Benue State. 
Participants in the FGDs were 16 regular 
tramadol users who were recruited in 
Buruku and Gboko Local Government 
Areas of Benue State using snowball 
method. Participants (tramadol users) 
included 12 (75.0%) males and 4 (25.0%) 
females between the ages of 18 and 35. 
Most of the participants were married 
and were into hard jobs like farming, 
building/construction, and transporta-
tion. Participants were from a varied ed-
ucational background, but all had com-
pleted at least primary education and 
had used tramadol without prescrip-
tion. Another set of participants (psy-
chiatrists) in the FGD included 5 (62.5%) 
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males and 3 (37.5%) females who were 
purposively selected from Federal Medi-
cal Centre, Makurdi and the Benue State 
University Teaching Hospital, Makurdi. 
All the participants had work experience 
of at least 3 years and had at one time 
or another treated Patients of tramadol 
addiction.
The FGDs with tramadol users were 
conducted to explore their knowledge 
of tramadol, its medical use, prescription 
status, dosage requirement and contra-
indications. Other knowledge areas ex-
plored include tramadol misuse, toler-
ance, dependence and addiction as well 
as effects of tramadol misuse, withdrawal 
symptoms and safe-withdrawal from 
tramadol use. The FGD session with the 
psychiatrists explored facts related to tra-
madol use and misuse which the psychia-
trists considered users of tramadol should 
know.
Information gathered from litera-
ture and the themes from the analysis 
of the FGDs were used to generate an 
item pool of 50 questions with five suit-
able domains namely: medical use (4 
items), prescription (6 items), misuse (14 
items), effect of misuse (19 items) and 
withdrawal/detoxification (7 items). A 
section on the demographic characteris-
tics of the participants was also created 
with 7 items bringing the total number 
of items to 57. The response options for 
the questionnaire were ‘True’ ‘False’ and 
‘Not Sure’. The option of ‘Not sure’ was 
included to avoid guessing by the re-
spondents. 
Second Stage: Validation
Validation of the questionnaire (TUM-
KAQ) was done in three phases namely, 
content validation, face validation and 
construct validation as described below:
Content validation
Copies of the draft questionnaire with 
a pool of 50 items were emailed to six ex-
perts including two psychiatrists, two ad-
diction counsellors, one pharmacist and 
one expert in test and measurement to 
rate the relevance of the test items to the 
measured domains using a 4-point Likert 
format: “the item is not relevant”, “the 
item is somewhat relevant”, “the item is 
quite relevant”, and “the item is highly 
relevant” with the numerical values of 
1, 2, 3 and 4 respectively. They were also 
requested to carry-out qualitative as-
sessment of the items that would make 
them suitable for the target group. Rating 
scores of 4 and 3 were converted to valid 
(1) and rating scores of 2 and 1 were con-
verted to invalid (0) and the scores were 
entered into Microsoft excel to compute 
the item-level content validity index (I-
CVI) and the scale-level content validity 
index (S-CVI) of the questionnaire. The 
cut-off point for retaining items was set at 
0.83 (Polit, Beck, & Owen, 2007). 
Face validation
To ensure the clarity and comprehen-
siveness of the items, copies of the ques-
tionnaire were given to 30 tramadol users 
to rate the degree of clarity and compre-
hensiveness of each item using a 4-point 
Likert format: “the item is not clear and 
understandable”, “the item is somewhat 
clear and understandable”, “the item is 
clear and understandable” and “the item 
is very clear and understandable”. Rating 
scores of 4 and 3 were converted to valid 
(1) and rating scores of 2 and 1 were con-
verted to invalid (0), and the scores were 
entered into Microsoft excel in computing 
item-level face validity index (I-FVI) and 
the scale-level face validity index (S-FVI) 
to identify those items that would be 
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retained or removed. The cut-off point 
was set at 0.83 (Yusoff, 2019). 
Construct validation
Under this phase of validation, the 
subheadings of sample and sampling, re-
search tool, data collection method, data 
analysis and ethical considerations are 
described.
Sample and sampling
Two hundred participants who were 
aged 18 to 35 years (age bracket for youth 
in Nigeria according to the National Policy 
on Youth Development, 2009), and who 
were screened positive for tramadol use 
using tobacco, alcohol, prescription medi-
cations and other substance use (TAPS) 
tool (McNeely et al., 2016), specifically 
indicating tramadol use were recruited 
from communities in Logo and Tarka Lo-
cal Government Areas of Benue State to 
participate in the study. There is no pre-
cise sample for item response theory (IRT) 
analysis of a knowledge questionnaire, 
however some studies recommended a 
range from 100 to 500 participants (Edel-
en & Reeve, 2007; Goni et al., 2020; Za-
hiruddin et al., 2018). The sample size of 
200 tramadol users was, therefore, con-
sidered sufficient for TUMKAQ validation. 
The chain-referral method of sampling 
was used. It is a technique for gathering 
research subjects through identification 
of an initial subject who is used to recruit 
others. The method was considered best 
for this study because of its suitability and 
effectiveness in studying sensitive and pri-
vate matters (Waters, 2015). The first few 
subjects that were identified through an 
informant were used in recruiting their fel-
low tramadol users after convincing them 
by explaining the purpose of the study and 
assuring them of confidentiality.
Research tool
A self-report 40-item TUMKAQ (after 
deleting 10 items for low I-CVI) was used 
for data collection. The questionnaire was 
structured along five domains namely, med-
ical use; prescription, misuse; effects of mis-
use, and withdrawal/ detoxification. Items 
were dichotomously scored with ‘correct’ 
answer getting a score of ‘1’ and ‘incorrect’ 
answer getting a score of ‘0’. The option of 
‘Not sure’ was also considered as ‘incorrect’ 
and was therefore given a score of ‘0’.
Data collection method
Data for this validation study were 
collected from April 2020 to May, 2020. 
The method of administration was face-
to-face and no questionnaire was lost in 
the process. Data were collected for IRT 
analysis, which was used to evaluate the 
difficulty and the discriminative abilities 
of the questionnaire items.
Data analysis
The item response theory (IRT) model 
was applied for data analysis using R-soft-
ware to assess the psychometric proper-
ties of the TUMKAQ. Two-parameter lo-
gistic IRT (2 PL IRT) model was specifically 
used because the aim was to estimate only 
the difficulty and discrimination param-
eters of the questionnaire items without 
the inclusion of guessing as a pseudo-pa-
rameter (Arifin & Yusoff, 2017). For the dif-
ficulty parameter, the acceptable range of 
-3 to +3 was used as a cut-off point while 
for discrimination, 0.25 to infinity was set 
as a cut-off point (Wyse, 2010). Item fit 
was measured using chi-square goodness-
of-fit, and items with p-values greater 
than 0.05 (P > 0.05) were considered fit in 
the model. Modified parallel analysis was 
applied to check the assumption of unidi-
mensionality of the items in the domains 
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with p-values greater than 0.05 confirming 
the assumption. Cronbach alpha was com-
puted to assess the internal consistency of 
the TUMKAQ. The cut-off was set at 0.70 
as acceptable reliability (Taber, 2018).
Ethical considerations
The study protocol was reviewed and 
approved by the Human Research Ethics 
Committee of Universiti Sains Malaysia 
(USM/JEPeM/19050316) and approval 
letters were obtained from the Local 
Councils of Logo and Tarka before data 
collection. After adequate briefing of the 
participants about the study and assur-
ance of confidentiality, informed consent 
was obtained from each participant who 
agreed to participate in the study.
RESULTS
Description of the Participants
Descriptive statistics were used to anal-
yse the demographic data of the partici-
pants as shown in Table 1 below:
Table 1. Descriptive analysis of demographic data (n = 200) 
Variables Mean (SD) n (%)



















White-collar job 4 (2.0)
Others 2 (1.0)
Tramadol Prescription Status
Prescribed for me 4 (2.0)
Not prescribed for me 196 (98.0)
Duration of Tramadol Use
Less than one year 27 (13.5)
One year 5 (2.5)
More than one year 168 (84.0)




The result of the content analysis 
showed that 10 out of 50 items had item-
level content validity index of less than 
0.83. Based on the cut-off point of 0.83 
(Polit et al., 2007), Q1 (0.67), Q4 (0.5), Q5 
(0.67), Q7 (0.67), Q12 (0.5), Q18 (0.67), 
Q21 (0.67), Q22 (0.5), Q31 (0.67) and 
Q48 (0.5) were deleted (I-CVIs < 0.83). 
The overall content validity index was 
0.86, indicating good content validity for 
the TUMKAQ. Some of the items were re-
phrased in line with expert suggestions as 
shown in Table 2.
Face Validity
The result of the face validity analysis 
showed that all items had I-FVIs of great-
er than 0.83 except Q24 that had I-FVI of 
0.33 (< 0.83). This means items were clear 
and understandable by the target group. 
However, Q24 was not removed based 
on expert advice that the item was im-
portant in the measurement of tramadol 
knowledge. It was rather, rephrased from 
“Tramadol misuse does not cause diffi-
culty in emptying of the bowels (constipa-
tion)” to “Prolonged use of tramadol does 
not cause difficulty in passing stools” for 
better clarity and comprehension. Over-
all, the TUMKAQ had good face validity 
index of 0.97 (FVI > 0.83).
Construct Validity
The IRT analysis showed the psycho-
metric properties of the TUMKAQ as 
shown in Table 3.
Based on the IRT results as presented 
in Table 3, Q12 in the misuse domain; 
Q32, Q34 and Q35 in the effects of mis-
use domain; and Q14 in withdrawal/de-
toxification domain were deleted for poor 
performances in both the difficulty and 
discrimination parameters (outside -3 to 
+3 range and < 0.25). In the medical use 
domain, Q7 and Q16 had poor discrimi-
native indices (a < 0.25), and the p-values 
for all the items in the domain indicated 
they were not fit in the model (p < .05). 
They were, however, retained for good 
performances in the difficulty parameter. 
In the prescription domain, all the items 
except Q4 had p-values less than .05 in-
dicating they were not fit in the model. 
These items were also retained for having 
good difficulty and discrimination indices 
(within the -3 to +3 range and > 0.25). In 
the misuse domain, apart from Q12 that 
was deleted, only Q17 had a poor discrim-
inative index (a < 0.25) with Q5, Q8, Q10 
and Q13 having p-values less than .05 
indicating misfit in the model. The items 
were, however, accepted because they 
had good difficulty indices. In the effects 
of misuse domain, apart from Q32, Q34 
Table 2. Result of the qualitative assessment of items
Item Suggestion Action taken
Q16 The item should be correctly written. Increasing 
the consumption of tramadol to get the desired 
effect is tolerance and not a cause of tolerance.
The question was rephrased: Increasing the 
consumption of tramadol to get desired effects 
is known as tolerance.
Q49 Eating fruits and vegetables helps in detoxifying 
(removing) tramadol from the body system. 
Select one
Fruits were removed from the question: Eating 
vegetables helps in detoxifying (removing) 




The word ‘chronic’ should be replaced with a 
better and friendlier word.
The word ‘chronic’ was replaced with 
‘prolonged’ in some of the items affected and 




Table 3. Result of item response theory (IRT) analysis (n = 200)
Domain S/N Item b  a χ2 (df=8) p-values
Medical Use Q1 Tramadol was originally produced to 
boost sexual stamina
0.3372698 0.8205658 150.5090 < .0001
Q7 Tramadol is medically used for 
relieving tiredness
-2.0373397 -0.2115521 196.3006 < .0001
Q16 Tramadol is meant for pain treatment 3.5212039 -0.2300538 195.4775 < .0001
Prescription Q2 Tramadol is strictly a prescription 
drug
3.1710875 0.3656307 17.7908 .0229
Q3 Tramadol is good for pregnant 
women
1.1685897 1.2410745 83.7627 < .0001
Q4 Tramadol should not be used by 
people younger than 18 years
0.1264903 18.3399667 1.5203 .9924
Q6 The maximum recommended dose 
for tramadol is 800 mg per day
1.3708777 1.1952604 57.6510 < .0001
Q15 Tramadol is an over-the-counter drug 2.2620281 0.4234638 40.2409 < .0001
Misuse Q5 Using tramadol for sexual satisfaction 
is not misuse of the drug
0.3757775 1.58385094 27.0159 .0007
Q8 Dissolving tramadol tablets in energy 
drinks before taking is non-medical
0.5943807 1.20083421 31.5248 .0001
Q9 Using tramadol to get energy for 
work constitutes tramadol misuse
1.3196685 2.20039265 8.5999 .3772
Q10 Using tramadol without doctor’s 
prescription is tramadol misuse
0.2208292 2.61161240 27.5748 .0006
Q11 Increasing the consumption of 
tramadol to get desired effects is 
known as tolerance
1.1548817 2.39031969 13.6745 .0907
Q12 Continuous use of tramadol makes 
one physically dependent on it
20.9823943 0.09512118 16.2105 .0395
Q13 Taking larger amounts of tramadol over 
time is a sign of tramadol addiction
-0.0199840 1.0579246 30.8196 .0002
Q17 Peer pressure can influence one into 
tramadol misuse
-1.5435334 0.14382681 10.1388 .2504
Q18 Experimentation is one of the factors 
that influence tramadol misuse
1.7208307 0.26438267 10.2131 .2504
Effects of 
Misuse
Q19 Itchy skin is one of the effects of 
prolonged use of tramadol
0.6074271 1.63150974 12.7815 .1196
Q20 Excessive sweating is not an effect of 
misusing tramadol
0.5527224 1.60791053 13.3562 .1002
Q21 Tramadol misuse does not cause 
psychiatric disorder
0.5346347 2.27490307 15.4608 .0508
Q22 Tramadol misuse causes convulsion 0.6349961 3.17671897 12.3739 .1353
Q23 Indigestion could be caused by 
prolonged use of tramadol
0.2735393 2.21463403 12.0749 .1479
Q24 Prolonged use of tramadol does not 
cause difficulty in passing stools
1.0810489 1.26108238 9.2759 .3196
Q25 Prolonged use of tramadol could 
cause heart attack
0.5979380 0.82665471 24.3748 .002
Q26 Irregular heart rate is not associated 
with tramadol misuse
0.9210071 0.83079090 11.6639 .1668
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and Q35 that were deleted, only Q31 and 
Q36 had poor discrimination abilities but 
were retained based on their good per-
formances in the difficulty parameter. All 
the items in the effects of misuse domain 
indicated fitness in the model (p > .05) ex-
cept Q25, Q27 and Q30 (p < .05). In the 
withdrawal/detoxification domain, all the 
items indicated unfitness in the model 
(p < .05) but were all retained because 
they performed well in both the difficul-
ty and discrimination parameters except 
Q14 that was deleted. A valid 35-item 
TUMKAQ was produced after deleting five 
items. The amount of information tapped 
by the items in the five domains were 
70.3%, 96.3%, 95.9%, 89.9% and 97.6% 
respectively. 
After deleting Q12, Q14, Q32, Q34 and 
Q35, the modified parallel analysis was 
applied to check the unidimensionality of 
the items in the domains. The assumption 
of unidimensionality was confirmed in the 
medical use, prescription and withdrawal/
detoxification domains (p = .7525, .4059 
and .396 respectively which were greater 
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Domain S/N Item b  a χ2 (df=8) p-values
Q27 Long-term use of tramadol decreases 
breathing rate
0.8408041 0.51405934 30.6380 .0002
Q28 Erectile dysfunction is not an effect 
of long-term tramadol use
1.2717371 0.36377542 12.7014 .1225
Q29 Prolonged use of tramadol by 
women of reproductive age could 
cause amenorrhea (absence of 
menstruation)
0.9470038 0.30539529 13.3240 .1012
Q30 A new-born baby whose mother was 
using tramadol during pregnancy 
could suffer from seizure
1.3964453 0.44861039 16.5485 .0352
Q31 Long-term use of tramadol delays the 
healing of a wound
1.2556181 0.21118082 7.7164 .4616
Q32 Tramadol misuse increases chances 
of contracting viral diseases
5.2470163 0.05769508 4.6151 .7978
Q33 Prolonged use of tramadol can 
disrupt social relationship
2.5201954 0.93047012 10.0230 .2634
Q34 Anxiety is associated with prolonged 
use of tramadol
-4.4003098 0.06877541 17.5300 .025
Q35 Prolonged use of tramadol does not 
lure one into stealing
-4.9314309 -0.04890723 9.1893 .3266
Q36 Tramadol misuse can disintegrate a 
family
-3.6190233 0.19103041 13.6657 .0909
Withdrawal/ 
Detoxification
Q14 Body pain is a withdrawal symptom 
of tramadol
-4.2205771 0.2084812 21.2238 .0066
Q38 Tapering tramadol is good for safe 
withdrawal
0.4648767 1.7619706 73.3110 < .0001
Q39 Eating vegetables helps in clearing 
tramadol from the body system
0.2621256 3.2987172 40.9371 < .0001
Q40 Regular physical exercise can help 
clear tramadol from the body system
0.1781576 1.4107788 58.4245 < .0001
b = difficulty, a = discrimination, χ2= chi-square, p-values < 0.05 are highlighted in bold
Table 3. Result of item response theory (IRT) analysis (n = 200) (continued)
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than .05). The assumption of unidimen-
sionality was however violated in the mis-
use domain (p = .0099 < .05) and the ef-
fects of misuse domain (p = .0099 < .05). 
Reliability
After deleting Q12, Q14, Q32, Q34 and 
Q35, Cronbach alpha was computed to as-
sess the internal consistency of the TUM-
KAQ. The result yielded a reliability coef-
ficient value of 0.78. This value is above 
the acceptable reliability coefficient value 
of 0.70 (Taber, 2018) indicating that TUM-
KAQ has good internal consistency.
DISCUSSION
A 35-item TUMKAQ in a self-report 
format has been developed to assess tra-
madol users’ knowledge about the drug 
they use. The analysis has shown that the 
questionnaire has satisfactory content 
and psychometric properties as it consists 
of relevant items with adequate coverage, 
good difficulty and discrimination indices. 
However, the chi-square goodness-of-fit 
results showed that many items (Q1, Q7 
and Q16 in the medical use domain; Q2, 
Q3, Q6 and Q15 in the prescription do-
main; Q5, Q8, Q10 and Q13 in the misuse 
domain; Q25, Q27 and Q30 in the effects 
of misuse domain; and Q37, Q38, Q39 
and Q40 in the withdrawal/detoxification 
domain) were not fit in the IRT models. 
The misfit was, however, ignored. The de-
cision for retaining the misfit items was 
taken in accordance with the observation 
that both the content validity and the psy-
chometric quality of a test as a whole may 
be affected by removing misfit items, and 
this may have an effect on the important 
outcome measures (Crişan, Tendeiro, & 
Meijer, 2017). 
The psychometric properties of TUM-
KAQ were evaluated and its face validity 
was determined unlike the KAP question-
naire on tramadol (Tafesh, 2013) and 
knowledge on drug abuse questionnaire 
(Geramian et al., 2012). Compared with 
the Brief Opioid Overdose Knowledge 
(BOOK) questionnaire (Dunn et al., 2016), 
TUMKAQ is longer (35 items) and specifi-
cally related to tramadol, while BOOK (12 
items) is concerned with overdose knowl-
edge on opioids generally without the 
mention of tramadol. 
TUMKAQ has been developed to cover 
the important knowledge areas about 
tramadol. Assessing individuals’ knowl-
edge about the medical use of tramadol 
as covered by this questionnaire is vital 
considering the critical role knowledge 
of indications for medications play in the 
correct use of drugs (Bosch-Lenders et 
al., 2016). The assessment of knowledge 
on the prescription status of tramadol as 
covered by TUMKAQ is equally important. 
This is because, knowing that a particular 
drug is strictly a prescription drug could 
help in avoiding self-medication and its 
attendant consequences (Singh, Trivedi, 
Elnour, & Patel, 2015). TUMKAQ also cov-
ers assessment of knowledge on what 
constitutes tramadol misuse and the ad-
verse effects. This is based on the belief 
that knowing the non-medical purposes 
and methods of drug use as well as its ad-
verse effects could encourage abstinence 
(Sussman, Miyano, Rohrbach, Dent, & 
Sun, 2007; Twombly & Holtz, 2008). The 
questionnaire also assesses the knowl-
edge about the withdrawal process and 
detoxification of tramadol. This will de-
termine the knowledge status on safe-
withdrawal from tramadol use, as abrupt 
withdrawal without medical detoxifica-
tion could be catastrophic.
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TUMKAQ can help specialists in health 
promotion, drug education, addiction 
counselling and even clinical identification 
of individuals who may be in need of edu-
cational interventions. Using this question-
naire for assessing individuals’ baseline 
knowledge about tramadol can help in 
determining the kind of information they 
need as well as the method of delivery and 
the duration. The questionnaire may as 
well serve as a valid and reliable tool for 
evaluating the effectiveness of educational 
interventions in tramadol misuse among 
those who use the drug and the at-risk 
groups. The TUMKAQ is primarily intended 
to be used in communities, rehabilitation 
centres and in clinics managing patients 
with tramadol addiction.
CONCLUSION
A 35-item TUMKAQ in a self-report for-
mat with adequate content and satisfac-
tory psychometric properties, and good 
internal consistency has been developed 
to assess knowledge about tramadol in 
the areas of medical use, prescription, 
misuse, effects of misuse and withdraw-
al/detoxification. It can be used in iden-
tifying individuals who may be in need of 
educational interventions. TUMKAQ can 
also help in determining the nature and 
content of educational interventions to 
correct misinformation about tramadol. 
The questionnaire can as well be used 
for the pre-test and post-test evaluation 
of educational interventions in tramadol 
abuse.
LIMITATIONS
The ability of this questionnaire to 
measure change in knowledge after an 
educational intervention has not been 
studied. It is, therefore, recommended 
that its’ ability should be studied before 
subjecting it to a wider application and 
epidemiological research. The factor 
structure has also not been verified, thus 
creating the need for a confirmatory fac-
tor analysis (CFA) in future to confirm the 
construct validity of the TUMKAQ.
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